Phase I Pharmacokinetic and Pharmacodynamic Study of Cetuximab, Irinotecan and Sorafenib in Advanced Colorectal Cancer

BACKGROUND: This phase Ib study was designed to determine the maximum tolerated doses (MTD) and dose limiting toxicities (DLTs) of irinotecan and cetuximab with sorafenib. Secondary objectives included characterizing the pharmacokinetics and pharmacodynamics and evaluating preliminary antitumor acti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Azad, Nilofer, Dasari, Arvind, Arcaroli, John, Taylor, Gretchen E., Laheru, Daniel A., Carducci, Michael A., McManus, Martine, Quackenbush, Kevin, Wright, John J., Hidalgo, Manuel, Diaz, Luis A., Donehower, Ross C., Zhao, Ming, Rudek, Michelle A., Messersmith, Wells A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2012
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674958/
https://ncbi.nlm.nih.gov/pubmed/22615057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-012-9820-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge